Eyetech To Announce Second Quarter 2005 Financial Results On July 27, 2005
2005年7月16日 - 2:30AM
PRニュース・ワイアー (英語)
Eyetech To Announce Second Quarter 2005 Financial Results On July
27, 2005 NEW YORK, July 15 /PRNewswire-FirstCall/ -- Eyetech
Pharmaceuticals, Inc. (NASDAQ:EYET), today announced that it plans
to report second quarter 2005 financial results on Wednesday, July
27, 2005 after the U.S. financial markets close. (Logo:
http://www.newscom.com/cgi-bin/prnh/20050407/EYETLOGO ) Eyetech's
senior management will hold a conference call and webcast to
discuss the results and provide a company update on Thursday, July
28, 2005 at 11:00 a.m. Eastern Time. Live audio of the conference
call will be available to investors, members of the news media and
the general public by dialing 888-275-0218 (in the United States)
or 706-679-7756 (internationally). A playback of the call will be
available through August 4, 2005 by dialing 800-642-1687, passcode
7698407 (in the United States) or 706-645-9291, passcode 7698407
(internationally). To access the call by live webcast, please log
on to the Investor Relations section of our corporate website at
http://www.eyetech.com/. An archived version of the webcast will be
available at the same location through August 4, 2005. About
Eyetech Pharmaceuticals, Inc. Eyetech Pharmaceuticals, Inc. is a
biopharmaceutical company that specializes in the development and
commercialization of novel therapeutics to treat diseases of the
eye. Eyetech's initial focus is on diseases affecting the back of
the eye. Eyetech is commercializing and further developing
Macugen(R) (pegaptanib sodium injection) with Pfizer Inc for the
treatment of neovascular AMD. Macugen is also being studied for
other indications including diabetic macular edema and retinal vein
occlusion. http://www.newscom.com/cgi-bin/prnh/20050407/EYETLOGO
http://photoarchive.ap.org/ DATASOURCE: Eyetech Pharmaceuticals,
Inc. CONTACT: Investors - Glenn Sblendorio, Chief Financial
Officer, T: +1-212-824-3100, F: +1-212-824-3240, E-mail: ; or Media
- Chris Smith, Public Relations & Corporate Communications, T:
+1-212-824-3203, F: +1-212-824-3240, E-mail: , both of Eyetech
Pharmaceuticals, Inc. Web site: http://www.eyetech.com/
Copyright
Eyetech (NASDAQ:EYET)
過去 株価チャート
から 5 2024 まで 6 2024
Eyetech (NASDAQ:EYET)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Eyetech Pharmaceuticals (MM) (ナスダック市場): 0 recent articles
その他のEyetech Pharmaceuticals (MM)ニュース記事